Edition:
India

Maria Sheahan

Jeff Mason is a White House Correspondent for Reuters and the 2016-2017 president of the White House Correspondents’ Association. He was the lead Reuters correspondent for President Barack Obama's 2012 campaign and interviewed the president at the White House in 2015. Jeff has been based in Washington since 2008, when he covered the historic race between Obama, Hillary Clinton and John McCain. Jeff started his career in Frankfurt, Germany, where he covered the airline industry before moving to Brussels, Belgium, where he covered the European Union. He is a Colorado native, proud graduate of Northwestern University and former Fulbright scholar.

Twitter handle: @jeffmason1

18 Aug 2017

Germany's Lufthansa gets first say on Air Berlin asset sale-union

BERLIN/FRANKFURT A first round of formal talks for the sale of insolvent German airline Air Berlin's assets will be held with its bigger local rival Lufthansa on Friday, ahead of other prospective bidders, a senior labour union official said.

16 Aug 2017

Air Berlin files for insolvency after Etihad withdraws support

BERLIN Air Berlin , Germany's second-largest airline, filed for bankruptcy protection on Tuesday after key shareholder Etihad Airways withdrew funding following years of losses, leaving valuable runway slots up for grabs. | Video

10 Aug 2017

Henkel counts on new products to tackle weak sales growth

LONDON/FRANKFURT Consumer goods group Henkel plans to roll out new beauty products in major markets France and Italy to bolster business after its second quarter growth in organic sales was the weakest in eight years.

18 Jul 2017

Lufthansa lifts profit target on bumper summer bookings

BERLIN/FRANKFURT German airline Lufthansa increased its profit target for 2017 after a busy summer for bookings that has been boosted by demand on North American routes and a strong Germany economy.

15 Jul 2017

Morphosys sees revenue boost from Janssen psoriasis drug

DUESSELDORF/FRANKFURT German biotech group Morphosys expects to receive royalties from psoriasis drug guselkumab for five months this year, its Chief Executive Simon Moroney said, after its licensee received U.S. regulatory approval.

14 Jul 2017

Morphosys sees revenue boost from Janssen psoriasis drug

DUESSELDORF/FRANKFURT German biotech group Morphosys expects to receive royalties from psoriasis drug guselkumab for five months this year, its Chief Executive Simon Moroney said, after its licensee received U.S. regulatory approval.

04 Jul 2017

Stada executives quit as Bain, Cinven prepare new bid

FRANKFURT Stada's chief executive and its head of finance resigned on Tuesday ahead of an imminent new takeover bid for the German generic drugmaker by buyout groups Bain Capital and Cinven.

27 Jun 2017

Bain, Cinven discussing new offer for Stada: sources

FRANKFURT Buyout groups Bain Capital and Cinven are talking to investors about a potential new offer for German generic drugmaker Stada after their 5.3 billion euro ($6 billion) bid fell through, people close to the matter said.

25 May 2017

Linde, Praxair reach agreement on details of merger

FRANKFURT German industrial gases group Linde and U.S. peer Praxair have reached a deal in principle on details of their proposed $70 billion merger, Linde said on Wednesday.

22 Apr 2017

German soccer bomb suspect wanted to drive down share price - prosecutor

FRANKFURT German police arrested a man on Friday suspected of detonating three bombs that targeted the Borussia Dortmund soccer team bus in the hope of forcing down the club's share price and making a profit on an investment, prosecutors said. | Video

Markets

  • Asia
  • U.S.
  • Europe
  • Sectors
Stock Search
Sensex 31,524.68 -270.78 -0.85%
Nikkei 19,470.41 -232.22 -1.18%
Hang Seng 27,047.57 -296.65 -1.08%
EUR/INR 75.370 +0.00%
USD/INR 64.090 +0.00%
GBP/INR 82.490 +0.00%
Gold 1,286.80 +0.40 +0.03%
Oil 48.73 +1.64 +3.48%
Corn 351.25 +0.75 +0.21%